Clinical Trial Update: Study of ALE.C04 in Patients With Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/Phase 2 study of ALE.C04 for head and neck cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• ALE.C04

Snippet

Sponsor: Alentis Therapeutics AG | Conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED